Tumor endothelial cell-derived Sfrp1 supports the maintenance of cancer stem cells via Wnt signaling
2024

Sfrp1 Supports Cancer Stem Cells in Tumors

Sample size: 14 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hayashi Yumiko, Hashimoto Masakazu, Takaoka Katsuyoshi, Takemoto Tatsuya, Takakura Nobuyuki

Primary Institution: Fukui University

Hypothesis

Does Sfrp1 play a role in maintaining cancer stem cells through Wnt signaling?

Conclusion

Sfrp1 is crucial for tumor growth by maintaining cancer stem cells via Wnt signaling.

Supporting Evidence

  • Sfrp1 is expressed in a subset of tumor endothelial cells.
  • Sfrp1 knockout mice showed reduced tumor growth compared to wild-type mice.
  • CSCs were maintained in the early tumor growth phase but decreased in the late phase in Sfrp1 KO mice.
  • Expression of Wnt signaling target genes decreased significantly in Sfrp1 KO mice during late tumor growth.

Takeaway

Sfrp1 is like a helper for cancer cells, making sure they can grow and survive by keeping special cells called cancer stem cells alive.

Methodology

The study used Sfrp1 knockout mice and flow cytometry to analyze cancer stem cell maintenance and tumor growth.

Limitations

The study did not explore the early stages of angiogenesis or the effects of Sfrp1 on tumor vascular structure.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s11626-024-00899-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication